Ts. Tracy et al., INVOLVEMENT OF MULTIPLE CYTOCHROME-P450 ISOFORMS IN NAPROXEN O-DEMETHYLATION, European Journal of Clinical Pharmacology, 52(4), 1997, pp. 293-298
Objective: A series of studies was undertaken to determine the cytochr
ome P450 isoform(s) involved in naproxen demethylation and whether thi
s included the same isoforms reported to be involved in the metabolism
of other NSAIDs. Methods: (S)-Naproxen was incubated with human liver
microsomes in the presence of a NADPH-generating system and the forma
tion of desmethylnaproxen was measured by high-performance liquid chro
matography (HPLC). To further clarify the specific isoforms involved,
experiments were conducted with preparations expressing only a single
P450 isoform (vaccinia virus-expressed cells and microsomes derived fr
om a lymphoblastoid cell line, each transfected with specific P450 cDN
As) as well as inhibition studies using human liver microsomes and put
ative specific P450 inhibitors. Results: In human liver microsomes (n
= 7), desmethylnaproxen formation was observed with a mean k(M) of 92
(21) mu mol.l(-1), V-max of 538 pmol.min(-1).mg(-1) protein and C-int2
(reflective of a second binding site) of 0.36 mu l.min(-1) mg(-1) pro
tein. This C-int2 term was added since Eadie-Scatchard analysis sugges
ted the involvement of more than one enzyme. Studies using putative sp
ecific P450 inhibitors demonstrated inhibition of this reaction by sul
faphenazole, (apparent Ki=1.6 mu mol.l(-1)), warfarin (apparent Ki=27
mu mol.l(-1)), piroxicam (apparent Ki=23 mu mol.l(-1)) and tolbutamide
(apparent Ki = 128 mu mol.l(-1)). No effect was observed when alpha-n
aphthoflavone and troleandomycin were employed as inhibitors, but reac
tion with furafylline produced, on average, a maximum inhibition of 23
%. At a naproxen concentration of 150 mu mol.l(-1) formation of desmet
hylnaproxen was observed in cells expressing P450 1A2, 2C8, 2C9 and it
s allelic variant 2C9R144C. To further characterize these reactions, s
aturation kinetics experiments were conducted for the P450s 1A2, 2C8 a
nd 2C9. The k(M) and V-max for P450 1A2 were 189.5 mu mol.l(-1) and 7.
3 pmol.min(-1).pmol(-1) P450, respectively. Likewise, estimates of k(M
) and V-max for P450 2C9 were 340.5 mu mol.l(-1) and 41.4 pmol.min(-1)
.pmol(-1) P450, respectively. Reliable estimates of k(M) and V-max cou
ld not be made for P450 2C8 due to the nonsaturable nature of the proc
ess over the concentration range studied. Conclusion: Multiple cytochr
ome P450 isoforms (P450 1A2, 2C8 and 2C9) appear to be involved in nap
roxen demethylation, although 2C9 appears to be the predominant form.